Is Biogen Inc (BIIB) a Winner in the Drug Manufacturers - General Industry?
Friday, December 02, 2022 06:29 AM | InvestorsObserver Analysts
Mentioned in this article
Biogen Inc (BIIB) leads the Drug Manufacturers - General industry with an overall score of 81. BIIB is up 32.09% so far this year after the company closed yesterday at $301.85. The overall score measures the company's performance based-off both short and long term indicators and means that BIIB scores better than 81% of the overall market.
BIIB has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on BIIB!
Biogen Inc is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 53. This means that, on average, the stocks in this industry score higher than 53% of the stock market.
